FindTrial
Sign In

Ultraprotective ventilation

DEVICE2 trials

Sponsors

Fundación para la Investigación Biosanitaria del Principado de Asturias, Hospices Civils de Lyon

Conditions

Acute Respiratory Distress SyndromeCOVID19Cardiogenic Pulmonary EdemaExtracorporeal Circulation; ComplicationsPneumoniaSars-CoV2Ventilator-Induced Lung Injury

Unknown Phase

Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)
CompletedNCT03041428
Fundación para la Investigación Biosanitaria del Principado de AsturiasCardiogenic Pulmonary Edema, Extracorporeal Circulation; Complications, Ventilator-Induced Lung Injury
Start: 2017-02-01End: 2021-03-01Updated: 2021-04-01
Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia
CompletedNCT04349618
Hospices Civils de LyonAcute Respiratory Distress Syndrome, COVID19, Pneumonia +1
Start: 2020-04-15End: 2022-06-16Updated: 2025-12-10

Related Papers

Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial.
2023-07-1213 citations
Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial
Trials2021-10-115 citations
Biotrauma during ultra-low tidal volume ventilation and venoarterial extracorporeal membrane oxygenation in cardiogenic shock: a randomized crossover clinical trial
Annals of Intensive Care2021-08-2816 citations